From Elsevier Business Intelligence
Including company and deal data plus articles from publications like IN VIVO, Start-Up, The RPM Report, and Medtech Insight.

Celgene Corp.

www.celgene.com

Most Recent Related Deals

Celgene to pay $2.9bn to acquire Abraxis BioScience, 6/2010
Celgene, Agios enter cancer metabolism deal, 4/2010
Celgene to buy Gloucester for $340mm up front, 12/2009
Gloucester brings in $5.7mm through sales of debt and rights, 8/2009
Gloucester Pharmaceuticals raises $20.3mm through Series D, 8/2009
Celgene to work on GlobeImmune's cancer candidates, 5/2009
Gloucester sells $47mm of its Series C convertible shares, 12/2008
Acceleron and Celgene develop bone loss candidate, 2/2008
Celgene buys Pharmion for $2.6bn in cash and stock, 11/2007
Celgene enters option agreement with PTC; makes investment, 9/2007

Most Recent Related Articles

Click an article to see a free preview (15 of 83).

Celgene Moves Into Solid Tumors With $2.9 Billion Abraxis Acquisition , Start-Up 7/2010
Celgene Teams Up With Agios In Long-Term Cancer Metabolism Pact, In Vivo 5/2010
Assessing REMS: Risk Management's Key Question -- Do The Programs Work? , Medtech Insight 3/2010
The Opioid REMS: Health Care Reform, One Class at a Time, Medtech Insight 2/2010
The A-List: 2009's Trend-Shaping Series A Financings, In Vivo 1/2010
Waking Up to REMS: Redefining Marketing (Part 3), Start-Up 12/2009
Vertex: Preparing to Go Commercial , Start-Up 9/2009
Start-Up Quarterly Statistics, Q2 2009, In Vivo 9/2009
Pharmaceutical/Biotechnology Deal Statistics Quarterly, Q2 2009, Start-Up 9/2009
Pricing Experiments: Pharmas Get Creative in Germany, Start-Up 7/2009
Millennium Prospers Under Takeda--But Will Takeda Get Full Value?, Start-Up 6/2009
Building Bone: Next-Generation Osteoporosis Therapies, In Vivo 4/2009
The Epigenetics (R)evolution, In Vivo 3/2009
The Cost-Sharing Solution: The New NICE Ticket, Start-Up 3/2009
Best of the Blog: IN VIVO, November 2008, Start-Up 12/2008

See all 83 articles about this company

Copyright © 2009 Elsevier Inc. All rights reserved. Elsevier Business Intelligence, www.ElsevierBI.com.
Contact us at (800) 332-2181, +1 (908) 547-2159, or custcare@elsevier.com.